Your browser doesn't support javascript.
loading
IL-33-ILC2 axis promotes anti-tumor CD8+ T cell responses via OX40 signaling.
Okuyama, Yuko; Okajima, Akira; Sakamoto, Nao; Hashimoto, Ayaka; Tanabe, Ryuto; Kawajiri, Akihisa; Kawabe, Takeshi; Ishii, Naoto.
Afiliação
  • Okuyama Y; Department of Microbiology and Immunology, Tohoku University Graduate School of Medicine, Sendai 980-8575, Japan.
  • Okajima A; Department of Microbiology and Immunology, Tohoku University Graduate School of Medicine, Sendai 980-8575, Japan.
  • Sakamoto N; Department of Microbiology and Immunology, Tohoku University Graduate School of Medicine, Sendai 980-8575, Japan.
  • Hashimoto A; Department of Microbiology and Immunology, Tohoku University Graduate School of Medicine, Sendai 980-8575, Japan.
  • Tanabe R; Department of Microbiology and Immunology, Tohoku University Graduate School of Medicine, Sendai 980-8575, Japan.
  • Kawajiri A; Department of Microbiology and Immunology, Tohoku University Graduate School of Medicine, Sendai 980-8575, Japan.
  • Kawabe T; Department of Microbiology and Immunology, Tohoku University Graduate School of Medicine, Sendai 980-8575, Japan.
  • Ishii N; Department of Microbiology and Immunology, Tohoku University Graduate School of Medicine, Sendai 980-8575, Japan. Electronic address: ishiin@med.tohoku.ac.jp.
Biochem Biophys Res Commun ; 637: 9-16, 2022 12 31.
Article em En | MEDLINE | ID: mdl-36375254
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T CD8-Positivos / Receptores OX40 / Interleucina-33 / Imunidade Inata / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Biochem Biophys Res Commun Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T CD8-Positivos / Receptores OX40 / Interleucina-33 / Imunidade Inata / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Biochem Biophys Res Commun Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão